These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 27590786

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M.
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Craniometric changes in patients with acromegaly from a surgical perspective.
    Ebner FH, Kürschner V, Dietz K, Bültmann E, Nägele T, Honegger J.
    Neurosurg Focus; 2010 Oct; 29(4):E3. PubMed ID: 20887128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R.
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [Abstract] [Full Text] [Related]

  • 7. Predictors of outcome following Gamma Knife surgery for acromegaly.
    Poon TL, Leung SC, Poon CY, Yu CP.
    J Neurosurg; 2010 Dec; 113 Suppl():149-152. PubMed ID: 21222293
    [Abstract] [Full Text] [Related]

  • 8. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
    De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
    [Abstract] [Full Text] [Related]

  • 9. Reduced intercarotid artery distance in acromegaly: pathophysiologic considerations and implications for transsphenoidal surgery.
    Ebner FH, Kuerschner V, Dietz K, Bueltmann E, Naegele T, Honegger J.
    Surg Neurol; 2009 Nov; 72(5):456-60; discussion 460. PubMed ID: 19963090
    [Abstract] [Full Text] [Related]

  • 10. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
    Freda PU, Wardlaw SL, Post KD.
    J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
    [Abstract] [Full Text] [Related]

  • 11. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.
    Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3411-8. PubMed ID: 9768640
    [Abstract] [Full Text] [Related]

  • 12. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
    Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
    Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernández I, Ovalle A, Mendoza V.
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [Abstract] [Full Text] [Related]

  • 15. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
    Tindall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH, Adams DA.
    J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
    [Abstract] [Full Text] [Related]

  • 16. Octreotide as primary therapy for acromegaly.
    Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL.
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [Abstract] [Full Text] [Related]

  • 17. Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations.
    Zada G, Cavallo LM, Esposito F, Fernandez-Jimenez JC, Tasiou A, De Angelis M, Cafiero T, Cappabianca P, Laws ER.
    Neurosurg Focus; 2010 Oct; 29(4):E8. PubMed ID: 20887133
    [Abstract] [Full Text] [Related]

  • 18. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K, Amirjamshidi M, Mehrazin A, Khalatbary I, Keynama M, Bokai H, Abdollahi M.
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [Abstract] [Full Text] [Related]

  • 19. Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery.
    Zirkzee EJ, Corssmit EP, Biermasz NR, Brouwer PA, Wiggers-De Bruine FT, Kroft LJ, Van Buchem MA, Roelfsema F, Pereira AM, Smit JW, Romijn JA.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4320-4. PubMed ID: 15356027
    [Abstract] [Full Text] [Related]

  • 20. Acromegaly: a review of current medical therapy and new drugs on the horizon.
    Fleseriu M, Delashaw JB, Cook DM.
    Neurosurg Focus; 2010 Oct; 29(4):E15. PubMed ID: 20887125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.